Summary & Overview
CPT 93623: Pharmacologic Stress Electrophysiology with Pacing
CPT code 93623 represents a diagnostic electrophysiology procedure in which the clinician infuses a pharmacologic agent to stress the heart and then stimulates and paces cardiac tissue to provoke arrhythmias that cannot be induced by standard stimulation alone. This test is clinically important for evaluating unexplained syncope, suspected inducible ventricular or supraventricular arrhythmias, and for guiding therapeutic decisions in complex arrhythmia management. Nationally, pharmacologic stress electrophysiology plays a role in risk stratification and procedural planning for advanced electrophysiology interventions.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find operational and clinical context for CPT code 93623, including where the service is typically performed and what clinical questions it addresses. The publication summarizes benchmarking and coverage themes relevant to these payers, highlights common billing and documentation elements associated with electrophysiology stress testing, and outlines the clinical scenarios that most commonly justify use of this code. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 93623 describes a pharmacologic stress procedure in which the provider stimulates and paces the heart by infusing a drug to pharmacologically stress the heart and detect underlying arrhythmia that cannot be induced by standard stimulation methods. This service is a specialized electrophysiology testing procedure focused on arrhythmia provocation using pharmacologic agents.
-
Service type: Diagnostic electrophysiology study with pharmacologic stress and pacing
-
Typical site of service: Hospital-based cardiac catheterization or electrophysiology lab; may also be performed in specialized outpatient electrophysiology centers where monitoring and resuscitative support are available
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with intermittent palpitations and near-syncope is referred to the electrophysiology service after noninvasive testing (ECG, ambulatory monitor) fails to reproduce clinically suspected tachyarrhythmia. The electrophysiologist performs a pharmacologic stress pacing study to provoke arrhythmia that cannot be induced with standard programmed electrical stimulation alone. The patient is prepped in an outpatient cardiac catheterization or electrophysiology lab, monitored with continuous telemetry, arterial oxygenation, and invasive or noninvasive blood pressure monitoring. A temporary intracardiac pacing catheter is placed and incremental pacing is performed while a provocative agent (for example, isoproterenol or another approved inotropic/chronotropic drug) is infused to increase sympathetic tone and myocardial excitability. The team documents baseline rhythm, pacing thresholds, hemodynamic response, arrhythmia onset and termination maneuvers, and any adverse events. Post‑procedure observation occurs in a monitored recovery area until rhythm and hemodynamics are stable and the provocative drug effects have resolved.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician interpretation or professional portion is reported separately from technical services. |
59 |